AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2023

Jan 27, 2023

30291_dirs_2023-01-27_b24f03d7-840c-4206-9aea-87f03c64d1ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2023-01-25

Reporting Person: Singhal Priya (Head of Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-25	Common Stock	A	1123	—	Acquired	2652.3923	Direct

Footnotes

F1: Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on March 2, 2020. The shares will vest on March 2, 2023.